Christopher Seet, MD, PhD

Christopher Seet, MD, PhD

Assistant Professor-in-Residence, Department of Medicine, Division of Hematology-Oncology

Specialty

Hematologic Malignancies, Bone Marrow Transplantation, Cellular Therapy and Immunotherapy

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Languages

English

Education

Fellowships

Hematology and Oncology, David Geffen School of Medicine at UCLA, 2011 - 2014
NIH/National Cancer Institute K08 Mentored Clinical Scientist Development Award, 2019-2024
NIH/UCLA CTSI KL2 Translational Science Award, 2017-2019
UCLA Broad Stem Cell Research Center Clinical Fellowship, 2016-2018
NIH/UCLA Hematology T32 Fellowship, 2013-2016
UCLA Special Training in Advanced Research (STAR) Fellowship, 2012-2018

Internship

Internal Medicine, Loyola University Medical Center, 2009

Degrees

PhD, University of California, Los Angeles, 2018
MD, University of Sydney, 2007
AB, University of Chicago, 2002

Residency

Internal Medicine, Loyola University Medical Center, 2008 - 2011

Board Certifications

American Board of Internal Medicine, Oncology 2019
American Board of Internal Medicine, Hematology, 2018
American Board of Internal Medicine, Internal Medicine, 2011

Contact Information

Clinical Interests

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Aplastic Anemia and Bone Marrow Failure, Myeloproliferative Disorders, Chronic Myelogenous Leukemia, Bone Marrow Transplantation, Cellular Therapy and Immunotherapy

Scientific Interests

Dr. Seet’s research is focused on the study of human T cell development, anti-tumor T cell responses, and improving cellular engineering approaches for cancer immunotherapy. Active research areas include enhancing T cell responses to AML and MDS; understanding and improving the development of engineered T cells from induced pluripotent stem cells; and characterizing new receptors and targets for tumor immunotherapy.

In the News

View more articles